Correlation Between Catalyst Biosciences and HTG Molecular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Biosciences and HTG Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Biosciences and HTG Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Biosciences and HTG Molecular Diagnostics, you can compare the effects of market volatilities on Catalyst Biosciences and HTG Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Biosciences with a short position of HTG Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Biosciences and HTG Molecular.

Diversification Opportunities for Catalyst Biosciences and HTG Molecular

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Catalyst and HTG is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Biosciences and HTG Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HTG Molecular Diagnostics and Catalyst Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Biosciences are associated (or correlated) with HTG Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HTG Molecular Diagnostics has no effect on the direction of Catalyst Biosciences i.e., Catalyst Biosciences and HTG Molecular go up and down completely randomly.

Pair Corralation between Catalyst Biosciences and HTG Molecular

If you would invest  57.00  in HTG Molecular Diagnostics on August 25, 2024 and sell it today you would earn a total of  0.00  from holding HTG Molecular Diagnostics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Catalyst Biosciences  vs.  HTG Molecular Diagnostics

 Performance 
       Timeline  
Catalyst Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Catalyst Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Catalyst Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Catalyst Biosciences and HTG Molecular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Biosciences and HTG Molecular

The main advantage of trading using opposite Catalyst Biosciences and HTG Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Biosciences position performs unexpectedly, HTG Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HTG Molecular will offset losses from the drop in HTG Molecular's long position.
The idea behind Catalyst Biosciences and HTG Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stocks Directory
Find actively traded stocks across global markets